CYP2C19 genetic mutations in North IndiansLAMBA, Jatinder K; DHIMAN, Radha K; KOHLI, Krishan K et al.Clinical pharmacology and therapeutics. 2000, Vol 68, Num 3, pp 328-335, issn 0009-9236Article

Correlation between omeprazole hydroxylase and CYP2C19 genotype in North IndiansLAMBA, Jatinder K; DHIMAN, Radha K; SINGH, Rajinder et al.European journal of clinical pharmacology. 2001, Vol 57, Num 9, pp 649-652, issn 0031-6970Article

PharmGKB summary: very important pharmacogene information for CYP2B6THORN, Caroline F; LAMBA, Jatinder K; LAMBA, Vishal et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 8, pp 520-523, issn 1744-6872, 4 p.Article

Genetic contribution to variable human CYP3A-mediated metabolismLAMBA, Jatinder K; LIN, Yvonne S; SCHUETZ, Erin G et al.Advanced drug delivery reviews. 2012, Vol 64, pp 256-269, issn 0169-409X, 14 p., SUPArticle

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestineZAMBER, Charis P; LAMBA, Jatinder K; YASUDA, Kazuto et al.Pharmacogenetics (London). 2003, Vol 13, Num 1, pp 19-28, issn 0960-314X, 10 p.Article

Common allelic variants of cytochrome P4503A4 and their prevalence in different populationsLAMBA, Jatinder K; LIN, Yvonne S; THUMMEL, Kenneth et al.Pharmacogenetics (London). 2002, Vol 12, Num 2, pp 121-132, issn 0960-314XArticle

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicityHARTFORD, Christine M; SHIWEI DUAN; DELANEY, Shannon M et al.Blood. 2009, Vol 113, Num 10, pp 2145-2153, issn 0006-4971, 9 p.Article

PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activatorsLAMBA, Vishal; YASUDA, Kazuto; LAMBA, Jatinder K et al.Toxicology and applied pharmacology. 2004, Vol 199, Num 3, pp 251-265, issn 0041-008X, 15 p.Article

Genetic contribution to variable human CYP3A-mediated metabolismLAMBA, Jatinder K; LIN, Yvonne S; SCHUETZ, Erin G et al.Advanced drug delivery reviews. 2002, Vol 54, Num 10, pp 1271-1294, issn 0169-409X, 24 p.Article

The Influence of CYP3A5 Genotype on Dexamethasone Induction of CYP3A Activity in African AmericansROBERTS, Patrick J; ROLLINS, Kristan D; KASHUBA, Angela D. M et al.Drug metabolism and disposition. 2008, Vol 36, Num 8, pp 1465-1469, issn 0090-9556, 5 p.Article

The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent : An in Vitro-in Vivo EvaluationISOHERRANEN, Nina; LUDINGTON, Shana R; WATKINS, Paul B et al.Drug metabolism and disposition. 2008, Vol 36, Num 1, pp 146-154, issn 0090-9556, 9 p.Article

Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humansLAMBA, Jatinder K; XIN CHEN; SCHUETZ, John D et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 6, pp 415-427, issn 1744-6872, 13 p.Article

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adultsGIVENS, Raymond C; LIN, Yvonne S; BOWLING, Amy L. S et al.Journal of applied physiology (1985). 2003, Vol 95, Num 3, pp 1297-1300, issn 8750-7587, 4 p.Article